Tara Nickerson

Chief Executive Officer | San Francisco, California, United States

Professional Overview

Tara Nickerson is a seasoned biopharmaceutical executive with over 20 years of experience driving strategic growth and innovation. As the Chief Executive Officer of Therini Bio, Inc., she leverages her deep industry expertise and visionary leadership to guide the company's drug development initiatives and business operations. Nickerson's diverse background spans roles in corporate development, business strategy, and scientific research, positioning her as a trusted advisor to early-stage companies navigating the complex biotech landscape.

Experience Summary

Current Role

As the Chief Executive Officer of Therini Bio, Inc. since 2024, Nickerson is responsible for setting the strategic direction of the company and overseeing all aspects of its business. Under her leadership, Therini Bio has accelerated the development of its innovative therapeutic pipeline, forged strategic partnerships, and secured significant funding to fuel the company's growth. Nickerson's deep understanding of the biotech industry and proven track record of success have been instrumental in driving Therini Bio's impact.

Career Progression

Prior to her current role, Nickerson held various senior-level positions in the biotech industry. As the Director on the Board of Directors at Inversago Pharma, she played a key role in guiding the company's strategic decisions, leading to its acquisition by Novo Nordisk in 2022. As the Chief Business Officer at Maze Therapeutics and Prothena Corporation plc, she spearheaded business development initiatives, forged strategic partnerships, and contributed to the advancement of the companies' drug pipelines.

Nickerson's early career experience includes serving as a Senior Scientist at Axys Pharmaceuticals and Celera Genomics, where she conducted cutting-edge research and contributed to scientific breakthroughs.

Academic Background

Nickerson holds a Ph.D. in Molecular Biology from the University of California, Berkeley, where she specialized in drug discovery and translational research. Her academic achievements and research contributions have been recognized through numerous publications in peer-reviewed journals and presentations at industry conferences.

Areas of Expertise

• Biopharmaceutical strategy and corporate development

• Therapeutic pipeline management and drug development

• Strategic partnerships and alliance management

• Scientific research and translational medicine

• Organizational leadership and team building

Professional Impact

Nickerson's leadership and industry expertise have been instrumental in driving the success of the companies she has been associated with. At Therini Bio, she has spearheaded the development of a robust therapeutic pipeline, forged key strategic partnerships, and secured significant funding to fuel the company's growth. Her contributions have been recognized through her appointment as an advisor and consultant to various early-stage biotech companies, where she provides valuable guidance and expertise.

Conclusion

With her extensive experience, strategic vision, and proven track record of success, Tara Nickerson is a highly respected leader in the biopharmaceutical industry. As the Chief Executive Officer of Therini Bio, she is poised to drive transformative change and make a lasting impact on the lives of patients through the development of innovative therapies.